Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond

Publication date: Available online 1 June 2018Source: Trends in Endocrinology & MetabolismAuthor(s): Shannon E. Mullican, Shamina M. RangwalaGrowth differentiation factor-15 (GDF15) is a circulating protein that has been implicated in multiple biological processes, including energy homeostasis, body weight regulation, and cachexia driven by cancer and chronic disease. The potential to target GDF15 in the treatment of energy-intake disorders, including obesity and anorexia, is an area of intense investigation, but has been limited by the lack of an identified receptor, signaling mechanism, and target tissue. GDNF family receptor α-like (GFRAL) was recently identified as the neuronal brainstem receptor responsible for mediating the anorectic actions of GDF15. Herein, we provide a brief overview of GDF15 biology with a focus on energy homeostasis, and highlight the implications of the recent receptor identification to this field and beyond.
Source: Trends in Endocrinology and Metabolism - Category: Endocrinology Source Type: research